PT  - JOURNAL ARTICLE
AU  - Hasan, A.
AU  - Susanto, H.
AU  - Tjahjono, V.R.
AU  - Kusdiantara, R.
AU  - Putri, E.R.M.
AU  - Hadisoemarto, P.
AU  - Nuraini, N.
TI  - A new estimation method for COVID-19 time-varying reproduction number using active cases
AID  - 10.1101/2020.06.28.20142158
DP  - 2020 Jan 01
TA  - medRxiv
PG  - 2020.06.28.20142158
4099  - http://medrxiv.org/content/early/2020/06/29/2020.06.28.20142158.short
4100  - http://medrxiv.org/content/early/2020/06/29/2020.06.28.20142158.full
AB  - We propose a new method to estimate the time-varying effective (or instantaneous) reproduction number of the novel coronavirus disease (COVID-19). The method is based on a discrete-time stochastic augmented compartmental model that describes the virus transmission. A two-stage estimation method, which combines the Extended Kalman Filter (EKF) to estimate reported state variables (active and removed cases) and a low pass filter based on a rational transfer function to remove short term fluctuations of the reported cases, is used with case uncertainties that are assumed to follow a Gaussian distribution. Our method does not require information regarding serial intervals, which makes the estimation procedure simpler without reducing the quality of the estimate. We show that the proposed method is comparable to common approaches, e.g., age-structured and new cases based sequential Bayesian models. We also apply it to COVID-19 cases in the Scandinavian countries: Denmark, Sweden, and Norway, where we see a delay of about four days in predicting the epidemic peak.Competing Interest StatementThe authors have declared no competing interest.Funding StatementNo external funding.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:Not applicable.All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesData cab be found in a link in the manuscript. https://github.com/agusisma/covid19